amifostine anhydrous has been researched along with Agranulocytosis in 4 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
Agranulocytosis: A decrease in the number of GRANULOCYTES; (BASOPHILS; EOSINOPHILS; and NEUTROPHILS).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Komaki, R | 1 |
| Lee, JS | 1 |
| Milas, L | 1 |
| Lee, HK | 1 |
| Fossella, FV | 1 |
| Herbst, RS | 1 |
| Allen, PK | 1 |
| Liao, Z | 1 |
| Stevens, CW | 1 |
| Lu, C | 1 |
| Zinner, RG | 1 |
| Papadimitrakopoulou, VA | 1 |
| Kies, MS | 1 |
| Blumenschein, GR | 1 |
| Pisters, KM | 1 |
| Glisson, BS | 1 |
| Kurie, J | 1 |
| Kaplan, B | 1 |
| Garza, VP | 1 |
| Mooring, D | 1 |
| Tucker, SL | 1 |
| Cox, JD | 1 |
| Glick, JH | 1 |
| Glover, D | 1 |
| Weiler, C | 1 |
| Norfleet, L | 1 |
| Yuhas, J | 1 |
| Kligerman, MM | 1 |
| Kalaycioglu, M | 1 |
| Bukowski, R | 1 |
| Avilés, A | 1 |
| Díaz-Maqueo, JC | 1 |
| Talavera, A | 1 |
| García, EL | 1 |
| Guzmán, R | 1 |
| Nambo, MJ | 1 |
1 review available for amifostine anhydrous and Agranulocytosis
| Article | Year |
|---|---|
Clinical status of the new cytoprotective agent, amifostine.
Topics: Agranulocytosis; Amifostine; Antineoplastic Agents; Bone Marrow Purging; Drug Synergism; Granulocyte | 1994 |
2 trials available for amifostine anhydrous and Agranulocytosis
| Article | Year |
|---|---|
Effects of amifostine on acute toxicity from concurrent chemotherapy and radiotherapy for inoperable non-small-cell lung cancer: report of a randomized comparative trial.
Topics: Adult; Aged; Aged, 80 and over; Agranulocytosis; Amifostine; Antineoplastic Combined Chemotherapy Pr | 2004 |
Bone marrow protection with amifostine in the treatment of high-risk malignant lymphoma.
Topics: Adult; Agranulocytosis; Amifostine; Antineoplastic Agents, Alkylating; Bone Marrow; Cyclophosphamide | 1997 |
1 other study available for amifostine anhydrous and Agranulocytosis
| Article | Year |
|---|---|
Phase I controlled trials of WR-2721 and cyclophosphamide.
Topics: Adult; Aged; Agranulocytosis; Amifostine; Cyclophosphamide; Drug Evaluation; Drug Therapy, Combinati | 1984 |